Free tools Windows power users keep installed
One-click scans. No signup required.
Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.
Candid Health raised a $52.5 million Series C on February 12, 2025, led by Oak HC/FT—just six months after its $29 million Series B. The two disclosed rounds total at least $81.5 million and position the company to expand its healthcare revenue-cycle automation platform.
Candid sells to healthcare organizations, not individual patients. Its software is designed to help medical groups, digital-health companies, managed-service organizations, and billing services submit insurance claims, track them, and reduce avoidable rework.
What happened in Candid Health’s funding round?
The Series C was led by Oak HC/FT, with participation from existing investors 8VC, First Round Capital, BoxGroup, and Y Combinator, according to TechCrunch’s coverage and investor commentary.
Recommended Free Tools
| Round | Amount | Timing | Lead investor |
|---|---|---|---|
| Series B | $29 million | August 2024 | 8VC |
| Series C | $52.5 million | February 12, 2025 | Oak HC/FT |
That means Candid disclosed at least $81.5 million in funding across the two rounds in roughly six months. The figure should not be interpreted as the company’s complete lifetime funding total unless additional financing is confirmed.
#1 Best Overall
Candid said the new capital would support customer expansion and further development of its revenue-cycle automation, including machine-learning tools intended to identify claims that may be denied and help correct them before submission.
The medical-billing problem Candid is targeting
Healthcare providers rarely bill a single payer under a single set of rules. They may submit claims to commercial insurers, Medicare, Medicaid, and other programs, each with different requirements for eligibility, coding, authorizations, documentation, claim formats, and submission deadlines.
A claim containing incorrect or incomplete information may be rejected or denied. That can lead to:
- delayed reimbursement;
- manual investigation and resubmission;
- additional appeals and payer follow-up;
- more work for billing and administrative staff; and
- cash-flow pressure for the provider.
Preventing an avoidable error before a claim is submitted is generally more efficient than repairing it later. But software cannot eliminate every denial. Eligibility changes, missing clinical documentation, authorization problems, medical-necessity disputes, coding judgment, and payer-policy disagreements can all require human review.
Candid CEO Nick Perry described medical billing as a data-engineering problem and argued that legacy systems have struggled to keep pace with healthcare’s complexity, according to TechCrunch. That is the company executive’s diagnosis—not an independently established finding that legacy systems cause most denials.
What Candid Health sells
Candid’s product is best understood as provider-side revenue-cycle infrastructure rather than simply “AI medical billing.” Its current platform materials emphasize:
- a rules engine for preparing cleaner claims;
- automated claims submission;
- reporting and revenue-cycle data tools;
- APIs and prebuilt integrations; and
- workflows for medical groups, digital-health organizations, managed-service organizations, and billing services.
The intended buyer is likely an operator responsible for revenue-cycle performance: a medical-group executive, digital-health company, billing-service provider, or revenue-cycle leader. The beneficiary may be the provider’s finance and billing team, while better claims handling can also support more predictable payments to the organization.
The company was founded in 2019 by Nick Perry and Doug Proctor. Y Combinator lists Candid as a Winter 2020 company based in San Francisco. Perry previously spent five years at Palantir, according to TechCrunch.
Why raise another round so quickly?
The short interval between the Series B and Series C suggests that Candid was seeking capital while pursuing rapid expansion. TechCrunch reported that the company’s revenue grew nearly 250% in 2024 and that it was moving beyond telehealth providers toward larger physician groups.
That growth figure is reported by TechCrunch and should not be confused with audited revenue, profitability, customer retention, or improved collection rates. The available reporting does not establish those metrics independently.
There are several practical reasons a revenue-cycle company might need substantial capital at this stage:
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstall- Integrations: Connecting to electronic health records, practice-management systems, clearinghouses, eligibility systems, and payer workflows can require significant engineering and implementation work.
- Payer coverage: Rules and reimbursement processes vary by payer, geography, specialty, and claim type. Expanding coverage requires ongoing data and operational investment.
- Customer implementation: Larger provider organizations typically have more complex workflows and longer deployment requirements than early digital-health customers.
- Sales and support: Enterprise healthcare software often requires specialized implementation, account management, compliance, and customer-service teams.
- Product development: Candid can invest in automation and machine learning before those tools are deployed across a broader customer base.
Where machine learning fits
Candid’s reported AI-related use case is relatively concrete: analyzing denial patterns, identifying claims that are likely to fail, and helping correct problems before submission. This is different from claiming that a generative-AI agent independently handles the entire billing process.
Rules, structured claims data, payer-specific logic, and reliable integrations remain fundamental. Machine learning may improve how the platform detects patterns or prioritizes exceptions, but it does not remove the need to keep payer rules current or verify the underlying clinical and administrative data.
TechCrunch also reported that Candid was considering a future capability for handling insurer calls related to denied claims. That was described as a possible direction, not as an established autonomous insurance-call product. Candid should therefore be described as an automation platform with expanding machine-learning capabilities—not as a fully autonomous billing agent.
Who uses Candid?
TechCrunch identified Allara, Nourish, and Talkiatry among Candid’s telehealth and digital-health customers. The company’s current website groups its target market into four categories:
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →- medical groups;
- managed-service organizations;
- digital-health organizations; and
- billing services.
Named customers provide examples, but they do not prove that the platform works equally well for every specialty or provider size. A billing workflow built for telehealth may face different requirements in surgery, hospital-based care, behavioral health, or highly specialized medicine.
How Candid compares with alternatives
TechCrunch described Candid’s competitive environment as including legacy billing systems associated with large electronic-health-record vendors such as Epic and athenahealth, as well as newer companies including Apero and Adonis. The competitive fit depends heavily on whether a buyer wants a modular revenue-cycle layer, a broader practice-management system, or a full health-system platform.
| Option | Potential fit | Trade-off |
|---|---|---|
| Candid Health | Digital-health companies, medical groups, and billing organizations seeking revenue-cycle automation and integrations | Sales-led implementation and no publicly listed pricing on the reviewed official pages |
| Apero | Practices seeking software oriented toward practice operations and related workflows | Buyers should verify whether the desired scope is standalone RCM automation or a broader practice platform |
| athenahealth | Organizations seeking a broader ambulatory-care platform with clinical, practice-management, and revenue-cycle capabilities | May require greater commitment to a broader suite than a modular billing layer |
| Epic | Large health systems or organizations already operating in the Epic ecosystem | Usually associated with a major enterprise deployment rather than a lightweight billing product |
| In-house or incumbent billing vendor | Organizations with established workflows and specialized internal expertise | May offer less flexibility or slower adaptation than a newer automation platform |
There is no evidence in the available material that Candid is cheaper than Epic, athenahealth, or other alternatives, and no market-share evidence supports calling it a market leader. Candid’s official site directs prospects toward a demo rather than publishing standard plan pricing, so buyers should expect a sales-led evaluation.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the funding does—and does not—prove
A $52.5 million financing round demonstrates investor confidence and gives Candid more resources. It does not, by itself, prove that the product reduces denial rates, improves collections, increases profitability, or delivers a positive return on investment for customers.
Those outcomes require customer-level evidence such as:
Best Value
- first-pass claim-acceptance rates;
- denial-rate changes by specialty and payer;
- days in accounts receivable;
- collection-rate improvements;
- billing staff-hours saved;
- implementation time; and
- customer retention and expansion.
The available coverage reports revenue growth and customer expansion but does not provide independently verified figures for those operating metrics.
Questions buyers should resolve before switching
Revenue-cycle software is deeply connected to a provider’s clinical and administrative systems. A product demo is not enough to assess switching risk. A serious evaluation should ask:
- What is supported? Confirm specialties, claim types, payers, geographies, coding workflows, authorizations, and appeals.
- What integrates? Identify supported EHRs, practice-management systems, clearinghouses, scheduling tools, eligibility systems, and data-export formats.
- What does Candid operate? Establish whether the engagement is software-only, managed billing, or a hybrid, and determine who owns payer follow-up and appeals.
- How is pricing calculated? Ask about per-claim charges, subscriptions, percentage-of-collections fees, implementation costs, and minimum commitments. Public pricing was not found on the reviewed official pages.
- How is automation controlled? Review approval workflows, audit logs, exception handling, correction policies, and human review requirements.
- How is patient information protected? Evaluate access controls, data handling, security documentation, and business-associate obligations for protected health information.
- How does migration work? Request a timeline, data-conversion plan, payer-enrollment responsibilities, testing process, and safeguards against cash-flow disruption.
- What evidence is available? Ask for customer references and measurable results rather than relying only on aggregate growth claims.
- What happens at exit? Confirm data ownership, export rights, contract termination terms, and the process for moving workflows to another system.
Bottom line
Candid Health’s rapid $52.5 million Series C, following a $29 million Series B, reflects investor interest in healthcare infrastructure that can connect billing data, payer rules, and automation. The opportunity is meaningful because preventable claim problems consume time and delay provider revenue.
The decisive test, however, is operational rather than financial. Candid will need to show repeatable improvements in claim acceptance, collections, and billing labor as it moves from digital-health customers into larger and more complex provider organizations. The funding provides the means to pursue that goal; it is not proof that the goal has already been achieved.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
